摘要 |
The present invention provides a compound of formula (I): wherein R<SUB>1</SUB>-R<SUB>5</SUB>, R<SUB>25</SUB>, R<SUB>26</SUB>, Y and X<SUB>2 </SUB>are as defined herein. The compounds activate human peroxisome proliferator activated receptors (hPPARs) and are useful for the treatment of associated disorders such as cardiovascular disease and hypercholesteremia.
|